WEDNESDAY, Sept. 27 (HealthDay News) -- The latest study on islet cell transplantation has both good and bad news for people with type 1 diabetes. The good news is that nearly half of those who receive an islet cell transplant are insulin-free at one year after transplant; the bad news is that by the end of the second year that number drops to about one in seven. Still, researchers expect that with improvements in the technical aspects of the procedure, and better anti-rejection drugs, those numbers will improve. "A phenomenal amount of glycemic control can be provided with islet transplantation,"...